Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines.


Journal

Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500

Informations de publication

Date de publication:
01 08 2020
Historique:
received: 25 11 2019
revised: 04 02 2020
accepted: 06 03 2020
pubmed: 12 3 2020
medline: 3 11 2021
entrez: 12 3 2020
Statut: ppublish

Résumé

Small-cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and highly aggressive ovarian malignancy. In almost all cases, it is associated with somatic and often germline pathogenic variants in

Identifiants

pubmed: 32156746
pii: 1078-0432.CCR-19-3797
doi: 10.1158/1078-0432.CCR-19-3797
pmc: PMC7415570
mid: NIHMS1600867
doi:

Substances chimiques

Nuclear Proteins 0
Transcription Factors 0
SMARCA4 protein, human EC 3.6.1.-
DNA Helicases EC 3.6.4.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3908-3917

Subventions

Organisme : CIHR
ID : FDN- 148390
Pays : Canada
Organisme : CIHR
ID : MOP-130540
Pays : Canada
Organisme : Cancer Research UK
ID : 27223
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C61296/A27223
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : K99 CA234391
Pays : United States
Organisme : CIHR
ID : PJT-156233
Pays : Canada
Organisme : NCI NIH HHS
ID : R01 CA195670
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016086
Pays : United States

Informations de copyright

©2020 American Association for Cancer Research.

Références

Science. 2018 Feb 16;359(6377):770-775
pubmed: 29301958
Hum Mutat. 2011 Feb;32(2):E1999-2017
pubmed: 21280140
Nat Med. 2015 Dec;21(12):1491-6
pubmed: 26552009
Nat Commun. 2019 Apr 23;10(1):1881
pubmed: 31015438
Int J Gynecol Pathol. 2004 Oct;23(4):330-6
pubmed: 15381902
Cell Rep. 2016 Oct 25;17(5):1265-1275
pubmed: 27783942
Mol Cancer Ther. 2017 May;16(5):850-860
pubmed: 28292935
N Engl J Med. 2010 Mar 18;362(11):1031-40
pubmed: 20237350
Nat Genet. 2014 May;46(5):424-6
pubmed: 24658004
Hum Mutat. 2008 May;29(5):617-22
pubmed: 18386774
Science. 2018 Feb 16;359(6377):801-806
pubmed: 29301960
Cell. 2018 Nov 15;175(5):1272-1288.e20
pubmed: 30343899
Gynecol Oncol Rep. 2015 Feb 25;12:20-2
pubmed: 26076152
Am J Surg Pathol. 2020 Feb;44(2):263-270
pubmed: 31567195
Nat Cell Biol. 2018 Dec;20(12):1410-1420
pubmed: 30397315
Cell Rep. 2016 Mar 15;14(10):2490-501
pubmed: 26947069
Pol J Pathol. 2013 Dec;64(4):238-46
pubmed: 24375037
J Pathol. 2017 Sep;243(1):9-15
pubmed: 28608987
Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3128-33
pubmed: 24520176
Conn Med. 2016 Oct;80(9):529-532
pubmed: 29772136
J Pathol. 2016 Feb;238(3):389-400
pubmed: 26356327
Clin Cancer Res. 2019 Apr 1;25(7):2278-2289
pubmed: 30563935
Mol Cell Biol. 2014 Mar;34(6):1136-44
pubmed: 24421395
Ann Oncol. 2007 Dec;18(12):1985-9
pubmed: 17761699
Annu Rev Med. 2015;66:455-70
pubmed: 25341009
Nat Rev Cancer. 2011 Jun 09;11(7):481-92
pubmed: 21654818
J Pathol. 2017 Jul;242(3):371-383
pubmed: 28444909
Sci Adv. 2015 Jun 12;1(5):e1500447
pubmed: 26601204
J Pathol. 2013 Sep;231(1):35-43
pubmed: 23775540
Nat Commun. 2019 Feb 4;10(1):558
pubmed: 30718512
Nat Genet. 2014 May;46(5):438-43
pubmed: 24658002
J Pathol. 2018 Apr;244(5):638-649
pubmed: 29359803
Oncogene. 2007 Oct 25;26(49):7058-66
pubmed: 17546055
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Natl Cancer Inst. 2018 Jul 1;110(7):787-790
pubmed: 29365144
Cancer Res. 2003 Feb 1;63(3):560-6
pubmed: 12566296
Am J Surg Pathol. 2015 Sep;39(9):1197-205
pubmed: 26135561
Gynecol Oncol Rep. 2017 Sep 28;22:45-47
pubmed: 29204511
Mol Cancer Ther. 2018 Dec;17(12):2767-2779
pubmed: 30232145
Nat Genet. 2019 Apr;51(4):618-626
pubmed: 30858614
Mod Pathol. 2016 Jan;29(1):60-6
pubmed: 26564006
J Pathol. 2014 Jul;233(3):209-14
pubmed: 24752781
Gynecol Oncol Rep. 2019 Feb 17;28:47-49
pubmed: 30886884
Nat Genet. 2015 Oct;47(10):1200-5
pubmed: 26343384
Cancer. 1994 Apr 1;73(7):1878-81
pubmed: 8137214
Genes Dev. 2013 Dec 15;27(24):2648-62
pubmed: 24285714
Surg Pathol Clin. 2016 Jun;9(2):215-26
pubmed: 27241105
Clin Cancer Res. 2018 Apr 15;24(8):1932-1943
pubmed: 29440177
Cancer Discov. 2018 Feb;8(2):216-233
pubmed: 29101163
Am J Surg Pathol. 1994 Nov;18(11):1102-16
pubmed: 7943531
Nature. 2017 Aug 24;548(7668):471-475
pubmed: 28813415
J Med Genet. 1996 Apr;33(4):333-5
pubmed: 8730291
Histopathology. 2016 Nov;69(5):727-738
pubmed: 27100627
Trends Genet. 2014 Aug;30(8):356-63
pubmed: 24932742
Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S30-4
pubmed: 25341577
Cancer Res. 2013 Sep 1;73(17):5508-18
pubmed: 23872584
Nat Rev Cancer. 2005 Sep;5(9):689-98
pubmed: 16110319
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv1-iv18
pubmed: 29697741
Cancer Cell. 2019 Dec 9;36(6):597-612.e8
pubmed: 31708437
Drug Saf. 2019 Feb;42(2):235-245
pubmed: 30649740
Rare Dis. 2014 Nov 03;2(1):e967148
pubmed: 26942101
Nat Genet. 2014 May;46(5):427-9
pubmed: 24658001
Lancet Oncol. 2020 Jan;21(1):121-133
pubmed: 31812554
PLoS One. 2013 Oct 30;8(10):e77652
pubmed: 24204904
Nat Commun. 2019 Feb 4;10(1):557
pubmed: 30718506
Nat Genet. 2013 Jun;45(6):592-601
pubmed: 23644491
Cell Tissue Res. 2014 Jun;356(3):575-84
pubmed: 24496512
Adv Anat Pathol. 2004 Nov;11(6):288-96
pubmed: 15505529
J Med Genet. 2018 Jan;55(1):1-10
pubmed: 29175835
Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12758-63
pubmed: 21768360
J Cancer. 2019 Jan 1;10(1):223-237
pubmed: 30662543
Cancer Res. 2019 May 15;79(10):2761-2774
pubmed: 30877105
Gynecol Oncol. 2016 Jun;141(3):454-460
pubmed: 26975901

Auteurs

Marc Tischkowitz (M)

Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom. mdt33@cam.ac.uk weissman@med.unc.edu.
East Anglian Medical Genetics Unit, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom.

Sidong Huang (S)

Department of Biochemistry, McGill University, Montreal, Quebec, Canada.
The Rosalind & Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.

Susana Banerjee (S)

The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom.

Jennifer Hague (J)

East Anglian Medical Genetics Unit, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom.

William P D Hendricks (WPD)

Translational Genomics Research Institute, Division of Integrated Cancer Genomics, Phoenix, Arizona.

David G Huntsman (DG)

BC Cancer, Vancouver, British Columbia, Canada.

Jessica D Lang (JD)

Translational Genomics Research Institute, Division of Integrated Cancer Genomics, Phoenix, Arizona.

Krystal A Orlando (KA)

Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.

Amit M Oza (AM)

Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.

Patricia Pautier (P)

Gustave Roussy, Villejuif, France.

Isabelle Ray-Coquard (I)

Centre Anti cancereux Léon Bérard, & University Claude Bernard Lyon, GINECO Group, Lyon, France.

Jeffrey M Trent (JM)

Translational Genomics Research Institute, Division of Integrated Cancer Genomics, Phoenix, Arizona.

Michael Witcher (M)

The Lady Davis Institute of the Jewish General Hospital, Department of Oncology, McGill University, Montreal, Canada.

Leora Witkowski (L)

Department of Human Genetics, McGill University, Montreal, Quebec, Canada.

W Glenn McCluggage (WG)

Department of Pathology, Belfast Health and Social Care Trust, Belfast, United Kingdom.

Douglas A Levine (DA)

Gynecologic Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York.

William D Foulkes (WD)

The Lady Davis Institute of the Jewish General Hospital, Department of Oncology, McGill University, Montreal, Canada.
Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Department of Medical Genetics, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
Department of Medical Genetics and Cancer Research Program, Research Institute of the McGill University Health Centre, McGill University, Montreal, Quebec, Canada.

Bernard E Weissman (BE)

Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina. mdt33@cam.ac.uk weissman@med.unc.edu.
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH